STF-083010

Alias: IRE1 Inhibitor I; STF-083010; STF 083010; STF083010
Cat No.:V1900 Purity: ≥98%
STF-083010 (formerly IRE1 Inhibitor I) is a novel and specific small-molecule inhibitor of IRE1α endonuclease.
STF-083010 Chemical Structure CAS No.: 307543-71-1
Product category: IRE1
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
5mg
10mg
25mg
50mg
100mg
250mg
500mg
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

STF-083010 (formerly IRE1 Inhibitor I) is a novel and specific small-molecule inhibitor of IRE1α endonuclease. In many solid tumors and hematologic malignancies, including multiple myeloma (MM), the adaptive Ire1-XBP1 pathway has been found to be activated. Following endoplasmic reticulum stress in both vitro and vivo, STF-083010 reduced Ire1 endonuclease activity without affecting its kinase activity. In models of human MM xenografts, STF-083010 treatment demonstrated significant antimyeloma activity. STF-083010, in contrast to other similarly isolated cell populations, was preferentially toxic to freshly isolated human CD138(+) MM cells. The discovery of this new Ire1 inhibitor lends credence to the idea that the Ire1-XBP1 axis represents a promising target for anticancer therapy, particularly in the context of MM. STF-083010 exhibits dose- and time-dependent cytostatic and cytotoxic activity in MM.1S, MM.1R, and RPMI 8226 MM cell lines. STF-083010 blocks IRE1α's endonuclease activity without affecting its kinase activity in the MiaPaCa2, Panc0403, and SU8686 cell lines. It also inhibits the splicing of XBP1. After three days of culture, STF-083010 shows a 70% growth inhibition in Eμ-TCL1 CLL cells. STF-083010 inhibits 20% of growth in MEC1 and MEC2 cells within 48 hours. WaC3 cells react to STF-083010 treatments by gradually slowing their growth.

Biological Activity I Assay Protocols (From Reference)
Targets
Ire1
ln Vitro
STF-083010 exhibits dose- and time-dependent cytotoxic and cytostatic activity in MM.1S, MM.1R, and RPMI 8226 MM cell lines.[1] [2] STF-083010 blocks IRE1's endonuclease activity in MiaPaCa2, Panc0403, and SU8686 cell lines without affecting XBP1 splicing or its kinase activity.[1] After three days of culture, STF-083010 shows a growth inhibition of about 70% in STF-083010 exhibits dose- and time-dependent cytotoxic and cytostatic activity in MM.1S, MM.1R, and RPMI 8226 MM cell lines. [1] [2] STF-083010 blocks IRE1's endonuclease activity in MiaPaCa2, Panc0403, and SU8686 cell lines without affecting XBP1 splicing or its kinase activity. [1] After three days of culture, STF-083010 shows a growth inhibition of about 70% in E-TCL1 CLL cells. In 48 hours, STF-083010 inhibits 20% of growth in MEC1 and MEC2 cells. WaC3 cells respond to STF-083010 treatments by gradually slowing their growth. [3]-TCL1 CLL cells. In 48 hours, STF-083010 inhibits 20% of growth in MEC1 and MEC2 cells. WaC3 cells respond to STF-083010 treatments by gradually slowing their growth. [3]
ln Vivo
STF-083010 (i.p., 30 mg/kg) significantly slows the growth of the tumor in a human multiple myeloma (MM) xenograft model. [1]
Enzyme Assay
The presence of 32P-γATP controls the activity of autophosphorylation. By adding radiolabeled HAC1 508-nt RNA substrate that has been in vitro synthesized using 32P-UTP, endonuclease activity is assessed. Radiolabeled HAC1 508 nt RNA, recombinant hIRE1 protein, and the appropriate buffers are all added to STF083010. Electrophoresis of polyacrylamide gels is used to measure kinase activity. 32P-γATP or 32P-UTP autoradiography is used to quantify the products of RNA scleavage.
Cell Assay
The following day, drug treatment was begun after 3000 cells were seeded in 96-well plates over night. The stop solution (4 mM HCl, 0.1% Nondet P40 in isopropanol), which is added to dissolve the MTT, is then added to the cells after 48 hours of incubation. MTT is added to the cells and cultured for 4 hours at 37°C. With a reference wavelength of 630 nm, a spectrophotometer reads the plates at 590 nm absorbance. Utilizing GraphPad Prism, IC50 values are computed.
Animal Protocol
Mice: The right and left hind footpads of each BALB/c nude mouse (male, 5 weeks old) are subcutaneously inoculated with 5×106 HCT116 p53+/+ or HCT116 p53-/- cells. After four days, DMSO or STF-083010 (40 mg/kg) is injected intraperitoneally every three days. Every five days, tumors are measured, and their volumes are calculated using the formula mm3=(length (mm))×(width (mm))2/2).
References

[1]. Blood . 2011 Jan 27;117(4):1311-4.

[2]. Oncotarget . 2014 Jul 15;5(13):4881-94.

[3]. Blood . 2012 Aug 2;120(5):1027-38.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C15H11NO3S2
Molecular Weight
317.38
Exact Mass
317.02
Elemental Analysis
C, 56.77; H, 3.49; N, 4.41; O, 15.12; S, 20.20
CAS #
307543-71-1
Appearance
Solid powder
SMILES
C1=CC=C2C(=C1)C=CC(=C2/C=N/S(=O)(=O)C3=CC=CS3)O
InChi Key
TVIVJHZHPKNDAQ-MHWRWJLKSA-N
InChi Code
InChI=1S/C15H11NO3S2/c17-14-8-7-11-4-1-2-5-12(11)13(14)10-16-21(18,19)15-6-3-9-20-15/h1-10,17H/b16-10+
Chemical Name
(NE)-N-[(2-hydroxynaphthalen-1-yl)methylidene]thiophene-2-sulfonamide
Synonyms
IRE1 Inhibitor I; STF-083010; STF 083010; STF083010
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ~63 mg/mL (~198.5 mM)
Water: <1 mg/mL
Ethanol: <1 mg/mL
Solubility (In Vivo)
2% DMSO+40%PEG 300+5% Tween80 +ddH2O: 2mg/mL (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.1508 mL 15.7540 mL 31.5080 mL
5 mM 0.6302 mL 3.1508 mL 6.3016 mL
10 mM 0.3151 mL 1.5754 mL 3.1508 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Biological Data
  • STF-083010


    The IRE1α inhibitor (STF-083010) suppresses the growth in vitro and in vivo of p53-deficient human cancer cells. From: Loss of p53 enhances the function of the endoplasmic reticulum through activation of the IRE1α/XBP1 pathway.2015 Aug 21;6(24):19990-20001.

  • STF-083010


    Anti-proliferative activities of IRE1αinhibitors. From: Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells.2014 Jul 15;5(13):4881-94.

  • STF-083010


    Effect of STF or HNA on expression of UPR target genes in pancreatic cancer cells. From: Selective inhibition of unfolded protein response induces apoptosis in pancreatic cancer cells.2014 Jul 15;5(13):4881-94.

Contact Us